In Brief: Novo Nordisk v. Becton Dickinson
This article was originally published in The Gray Sheet
Executive Summary
Novo Nordisk v. Becton Dickinson: Novo Nordisk files patent suit against Becton Dickinson in the U.S. District Court for the Southern District of New York. The suit alleges that BD's UltraFine II 30 gauge insulin delivery needle, a component of its BD Pen insulin delivery pen system, infringes a U.S. Novo Nordisk patent. The patent relates to Novo Nordisk's NovoFine 30 G insulin needle used in the NovoPen 1.5 insulin delivery system. The suit also alleges trademark infringement due to use of "packaging materials with false and misleading statements concerning Novo Nordisk products and trademarks." BD says it has not been served with the complaint and has not filed a response...